Screening for colorectal neoplasms with a new immunological human faecal haemoglobin and albumin test

European Journal of Cancer Prevention

Volumn 7, Issue 4, 1998, Pages 279-285

  Sieg, A ^a,b,d   Hertel, A ^a,b   John, M R ^b,c   Luthgens K ^c   Schmidt Gayk, H ^c,d  

^a Practice of Gastroenterology   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c Laboratory Group   (Germany)

^d Department of Clinical Chemistry ^*  (Germany)

Author keywords

Adenomatous polyps; Albumin; Colonic polyps; Colorectal cancer; Faeces; Haemoglobin; Occult blood; Screening

Indexed keywords

ALBUMIN;

ADENOMATOUS POLYP; ADULT; AGED; ARTICLE; CANCER SCREENING; CANCER STAGING; COLON POLYP; COLONOSCOPY; COLORECTAL TUMOR; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FECES ANALYSIS; FEMALE; GASTROINTESTINAL HEMORRHAGE; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALBUMINS; COLORECTAL NEOPLASMS; FECES; FEMALE; HEMOGLOBINS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PREDICTIVE VALUE OF TESTS;

EID: 0031665931     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008469-199808000-00003     Document Type: Article

References (30)

1. Ahlquist DA, Wicand HS, Moertel CG et al (1993). Accuracy of fecal occult-blood screening for colorectal neoplasia: a prospective study using Hemoccult and Hemoquant tests. JAMA 269: 1262-7.
2. Allison JE, Tekawa IS, Ransom LR, Adrain AL (1996). Comparison of fecal occult-blood tests for colorectal cancer screening. N Engl J Med 334: 155-9.
3. Frommer DJ, Kapparis A, Brown MK (1988). Improved screening for colorectal cancer by immunological detection of occult-blood. BMJ 96: 1092-4.
4. Gao P, John MR, Schmidt-Gayk H et al (1995). Solid-phase competitive luminescence immunoassay for lysozyme in faeces. Clin Chim Acta 239: 167-77.
5. Gnauck R (1995). Screening for colon cancer in Germany. Tumori 81: 30-7.
6. Hardcastle JD, Chamberlain JO, Robinson MHE et al (1996). Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 348: 1472-7.
7. Henson DE, Hutter RVP, Sobin LH, Bouman HE (1994). Protocol for the examination of specimens removed from patients with colorectal carcinoma: a basis for checklists. Arch Pathol Lab Med 118: 122-5.
8. Hisamichi S, Fukao A, Fuijii Y et al (1991). Mass screening for colorectal cancer in Japan. Cancer Detect Prev 15: 351-6.
9. John MR , Schmidt-Gayk H, Sieg A (1997). Screening for colorectal cancer. 4th reply (Letter to the editor). Lancet 349: 357-8.
10. Kronborg O, Fenger C, Olson J, Jörgensen OD, Söndergaard O (1996). Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 348: 1467-71.
11. Liebermann DA (1995). Cost-effectiveness model for colon cancer screening. Gastroenterology 109: 1781-90.
12. Mandel JS, Bond JH, Church TR et al (1993). Reducing mortality from colorectal cancer by screening for fecal occult-blood. N Engl J Med 328: 1365-71.
13. Mulcahy HE, Farthing MJG, O'Donoghue DP (1997). Screening for asymptomatic colorectal cancer. BMJ 314: 285-91.
14. Potter JD (1996). Epidemiologic, environmental, and lifestyle issues in colorectal cancer. In: Prevention and Early Dectection of Colorectal Cancer (eds Young GP, Rozen P, Levin B); WB Saunders, London, Philadelphia, Toronto, Sydney, Tokyo, pp. 23-43.
15. Ransohoff DF, Lang CA (1997). Screening for colorectal cancer with the fecal occult blood test: a background paper. Ann Intern Med 126: 811-22.
16. Rex DK, Rahmani EY, Hasemann J et al (1997). Relative sensitivity of colonoscopy and barium enema for detection of colorectal cancer in clinical practice. Gastroenterology 112: 17-23.
17. Robinson MHE, Marks CG, Farrands PA et al (1995). Is an immunological faecal occult-blood test better than Haemoccult? A cost-benefit study. Eur J Surg Onc 21: 261-4.
18. Saah AJ, Hoover DR (1997). Sensitivity and specificity reconsidered: The meaning of these terms in analytical and diagnostic settings. Ann Intern Med 126: 91-4.
19. Schütz E, Stolte M (1994). Zur Kosten-Nutzen-Analyse der konservativen Therapie der Gastritis und des Ulkusleidens. Leber Magen Darm 24: 147-9
20. Sieg A, Schröter M, Schmidt-Gayk H (1995). Screening for fecal occult blood: Validity of a new immunologic method for human hemoglobin and albumin. Gut 37(Suppl 2): A17.
21. Sieg A, Scheida M, John MR et al (1998). Validity of new immunological human fecal hemoglobin and albumin tests in detecting colorectal neoplasms. An endoscopy controlled study. Z Gastroenterol 36: 485-90.
22. Songster CL, Barrows GH, Jarrett DD (1980). Immunochemical detection of fecal occult-blood. The fecal smear punch-disc test: A new non-invasive screening test for colorectal cancer. Cancer 45: 1099-102.
23. Statistisches Bundesamt Wiesbaden (1996). Todesursachen. Statistisches Jahrbuch 1996. Fachserie 12, Metzler-Poeschel, Stuttgart.
24. St. John DJB, Young GP, Alexeyeff MA et al (1993). Evalutation of new occult blood tests for detection of colorectal neoplasia. Gastroenterology 104: 1661-8.
25. Toribara NW, Sleisinger MH (1995). Screening for colorectal cancer. N Engl J Med 332: 861-7.
26. Wahrendorf J, Robra BP, Wiebelt H, Oberhausen R (1993). Effectiveness of colorectal cancer screening: results from a population-based case-control evaluation in Saarland, Germany. Eur J Cancer Prev 2: 221-7.
27. Whynes DK, Walker AR, Hardcastle JD (1992). Effect of subject age on costs of screening for colorectal cancer. J Epidemiol Comm Hlth 46: 577-81.
28. Winawer SJ, Zauber AG, Ho MN et al and the National Polyp Study Workgroup (1993). Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 329: 1977-81.
29. Winawer SJ, Fletcher RH, Miller L et al (1997). Colorectal cancer screening: Clinical guidelines and rationale. Gastroenterology 112: 594-642.
30. Zauber AG, Winawer SJ (1995). Colonoscopic polypectomy reduces the incidence of colorectal cancer: Results of the National Polyp Study. Proc Ass Am Phys 107: 205-10.